FROM YAHOO NEWS
Latest news, live updates as 2024 election results loom
NasdaqGM - Nasdaq Real Time Price USD
Fulcrum Therapeutics, Inc. (FULC)
At close: November 5 at 4:00 PM EST
After hours: November 5 at 5:24 PM EST
Research Analysis
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 9 | 9 | 9 | 9 |
| Avg. Estimate | -0.41 | -0.34 | -0.28 | -1.22 |
| Low Estimate | -0.47 | -0.56 | -0.57 | -2.84 |
| High Estimate | -0.37 | -0.17 | -0.07 | -0.47 |
| Year Ago EPS | -0.39 | -0.4 | -1.59 | -0.28 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 8 | 8 | 8 | 7 |
| Avg. Estimate | -- | -- | 80.35M | -- |
| Low Estimate | -- | -- | 80M | -- |
| High Estimate | -- | -- | 82.83M | -- |
| Year Ago Sales | 1.05M | 871k | 2.81M | 80.35M |
| Sales Growth (year/est) | -- | -- | 2,764.50% | -- |
Earnings History
| CURRENCY IN USD | 9/30/2023 | 12/31/2023 | 3/31/2024 | 6/30/2024 |
|---|---|---|---|---|
| EPS Est. | -0.43 | -0.43 | -0.44 | -0.01 |
| EPS Actual | -0.39 | -0.4 | -0.43 | 0.87 |
| Difference | 0.04 | 0.03 | 0.01 | 0.88 |
| Surprise % | 9.30% | 7.00% | 2.30% | 8,800.00% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.41 | -0.34 | -0.28 | -1.22 |
| 7 Days Ago | -0.41 | -0.34 | -0.28 | -1.22 |
| 30 Days Ago | -0.41 | -0.34 | -0.28 | -1.23 |
| 60 Days Ago | -0.41 | -0.43 | -0.38 | -1.49 |
| 90 Days Ago | -0.42 | -0.44 | -0.38 | -1.43 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | 1 | 1 | 1 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | FULC | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -5.10% | -- | -- | 5.40% |
| Next Qtr. | 15.00% | -- | -- | 11.80% |
| Current Year | 82.40% | -- | -- | 2.20% |
| Next Year | -335.70% | -- | -- | 12.50% |
| Next 5 Years (per annum) | 16.40% | -- | -- | 11.03% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Upgrades & Downgrades
| Downgrade | RBC Capital: Outperform to Sector Perform | 9/13/2024 |
| Downgrade | HC Wainwright & Co.: Buy to Neutral | 9/13/2024 |
| Downgrade | Leerink Partners: Outperform to Market Perform | 9/12/2024 |
| Downgrade | B of A Securities: Neutral to Underperform | 9/12/2024 |
| Downgrade | Stifel: Buy to Hold | 9/12/2024 |
| Downgrade | Cantor Fitzgerald: Overweight to Neutral | 9/12/2024 |
Related Tickers
RPTX Repare Therapeutics Inc.
3.9000
+8.94%
TCRX TScan Therapeutics, Inc.
5.29
+4.13%
FDMT 4D Molecular Therapeutics, Inc.
8.39
+2.63%
REPL Replimune Group, Inc.
12.02
0.00%
RNA Avidity Biosciences, Inc.
45.09
+0.60%
HLVX HilleVax, Inc.
1.8900
-0.53%
RAPT RAPT Therapeutics, Inc.
2.4500
+7.93%
CABA Cabaletta Bio, Inc.
4.2000
+5.00%
LXEO Lexeo Therapeutics, Inc.
8.03
-2.55%
TRDA Entrada Therapeutics, Inc.
18.62
+4.78%